FDA Drugs recall ·

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains:… recall

This is an FDA Class I recall — the most serious type.

Recall number
D-0866-2026
Date
(initiated August 21, 2026)
Company / brand
Vitruvias Therapeutics Inc
778 N Dean Rd Ste 600, Auburn, AL, United States
Category
Drugs › Class I
Classification
Class I
Status
Ongoing
Units affected
1955 bottles
Hazard tags
Potency
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Why was it recalled?

Superpotent Drug

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot # 504950, Exp Date: 09/30/2026.

Distribution

US Nationwide.

What does Class I mean?

Class I is the most serious FDA recall class: there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.

Source: FDA (drugs), recall D-0866-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.